hydralazine has been researched along with felodipine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (41.67) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Adams, MA; Friberg, P; Thompson, KE | 1 |
| Jacinto, SM; Jandhyala, BS | 1 |
| Cross, AJ; Davies, EM; DeSouza, RJ; Green, AR | 1 |
| Björkman, JA; Ek, L; Gustafsson, D; Ljung, B; Nordlander, M | 1 |
| Strauer, BE | 1 |
| Chintala, MS; Jandhyala, BS | 1 |
| DiBona, GF | 2 |
| Dahlöf, B; Gudbrandsson, T; Hansson, L; Hellsing, T; Kullman, S; Kuylenstierna, J; Leppert, J; Möller, B; Skogström, K; Svensson, A | 1 |
| Littler, WA; Smith, SA | 1 |
| Andersson, OK; Granérus, G; Hedner, T | 1 |
| Hedner, T | 1 |
| Muir, AL; Wathen, CG | 1 |
| Hannan, WJ; Muir, AL; Wathen, CG | 1 |
| Nordlander, M | 1 |
| Cohn, JN | 1 |
3 review(s) available for hydralazine and felodipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antihypertensive agents--the race for third place.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diazoxide; Felodipine; Humans; Hydralazine; Indoramin; Labetalol; Minoxidil; Nicardipine; Nifedipine; Vasodilator Agents; Verapamil | 1985 |
Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Exercise; Felodipine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Norepinephrine; Oxygen Consumption; Prognosis; Stroke Volume; Survival Analysis | 1994 |
4 trial(s) available for hydralazine and felodipine
| Article | Year |
|---|---|
Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Felodipine; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nitrendipine; Random Allocation | 1988 |
Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. Cooperative Study Group.
Topics: Adult; Aged; Antihypertensive Agents; Double-Blind Method; Felodipine; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nifedipine; Random Allocation | 1986 |
Clinical evaluation of felodipine in hypertensive patients previously treated with a triple drug regimen.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Felodipine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Nitrendipine | 1987 |
The use of felodipine in the treatment of severe hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Felodipine; Female; Humans; Hydralazine; Hypertension; Male; Minoxidil; Nitrendipine; Random Allocation | 1987 |
17 other study(ies) available for hydralazine and felodipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Vasodilators inhibit acute alpha 1-adrenergic receptor-induced trophic responses in the vasculature.
Topics: Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressure; Drug Combinations; Felodipine; Heart Rate; Hydralazine; Male; Mesenteric Arteries; Methoxamine; Ornithine Decarboxylase; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Vasodilator Agents | 1992 |
Evaluation of the effects of felodipine, verapamil and hydralazine on the survival rate of rats subjected to lethal effects of oxygen free radicals.
Topics: Animals; Blood Pressure; Creatine Kinase; Felodipine; Heart Rate; Hydralazine; Male; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Survival Rate; Verapamil; Xanthine; Xanthine Oxidase; Xanthines | 1992 |
The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Brain Chemistry; Calcium Channel Blockers; Felodipine; Hydralazine; Hydroxyindoleacetic Acid; Male; Methoxydimethyltryptamines; Mice; Mice, Inbred C57BL; Rats; Receptors, Serotonin; Serotonin; Species Specificity; Tetrahydronaphthalenes; Tranylcypromine; Tryptophan | 1990 |
Acute haemodynamic effects of felodipine, verapamil and hydralazine in the anaesthetized dog.
Topics: Animals; Catecholamines; Dogs; Felodipine; Hemodynamics; Hydralazine; Verapamil | 1991 |
Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure.
Topics: Adult; Animals; Cardiac Output, Low; Cardiomegaly; Coronary Circulation; Coronary Disease; Coronary Vessels; Felodipine; Humans; Hydralazine; Hypertension; Metoprolol; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Resistance | 1990 |
Comparative evaluation of the effects of felodipine, hydralazine, and naloxone on the survival rate in rats subjected to a "fixed volume" model of hemorrhagic shock.
Topics: Animals; Blood Pressure; Blood Volume; Bloodletting; Felodipine; Heart Rate; Hematocrit; Hydralazine; Male; Naloxone; Rats; Rats, Inbred Strains; Shock, Hemorrhagic; Survival Rate | 1990 |
Effects of vasodilator antihypertensive agents on renal function.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dogs; Felodipine; Hydralazine; Kidney; Kidney Function Tests; Minoxidil; Nitrendipine; Rats; Rats, Inbred SHR; Vasodilator Agents | 1987 |
Felodipine in combination with a beta-blocker and a diuretic in chronic treatment of patients with refractory primary hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Felodipine; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nitrendipine; Renal Circulation | 1987 |
Effects of felodipine on resistance and capacitance vessels in patients with essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Vessels; Electrocardiography; Felodipine; Heart Rate; Humans; Hydralazine; Hypertension; Middle Aged; Nifedipine; Nitroglycerin; Stroke Volume; Vascular Resistance | 1985 |
Effects of felodipine on renal function in animals.
Topics: Animals; Antihypertensive Agents; Dogs; Felodipine; Glomerular Filtration Rate; Hemodynamics; Hydralazine; Hypertension; Kidney; Nifedipine; Potassium; Rats; Rats, Inbred SHR; Renal Circulation; Sodium | 1985 |
Haemodynamic effects of short and long term administration of felodipine in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Cardiac Output; Coronary Circulation; Drug Administration Schedule; Felodipine; Female; Heart Rate; Hemodynamics; Hydralazine; Hypertension; Male; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex; Regional Blood Flow; Stroke Volume; Time Factors | 1985 |